Don’t miss the latest developments in business and finance.

IOL Chemicals receives COPP certificate for ibuprofen and lamotrigine

The receipt of certificates of pharmaceuticals products (COPP) from Punjab's Food & Drugs Administration (FDA) will facilitate IOLCP to broaden its presence in export market

IOL Chemicals receives COPP certificate for ibuprofen and lamotrigine
BS B2B Bureau Mumbai
Last Updated : Mar 05 2016 | 11:45 AM IST
IOL Chemicals & Pharmaceuticals Ltd (IOLCP) has received certificates of pharmaceuticals products (COPP) for manufacturing facilities of ibuprofen and lamotrigine in its existing multi-purpose plant from Food & Drugs Administration, Punjab. This will facilitate IOLCP to broaden its presence in export market.
 
While ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of various types of pains, lamotrigine is an anti-convulsant drug used for treating epileptic seizures.
 
IOL Chemicals already has US FDA and European Directorate for the Quality of Medicines & Healthcare (EDQM) approved ibuprofen manufacturing facilities.

Also Read

First Published: Mar 04 2016 | 11:42 AM IST

Next Story